Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $105.57, up from yesterday’s close by -0.09%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.
No amount of research is complete without a bird’s eye view of the financial data. Intercept Pharmaceuticals, Inc. (ICPT) currently trades with a market capitalization of $2.62B. That value represents a market adjusting for revenues that have been growing by 1,063.40% on a quarterly year/year basis as of the company’s last quarterly report.
The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For ICPT, the company currently has $779.96M of cash on the books, which is offset by $337.90M current liabilities. You can get a sense of how sustainable that is by a levered free cash flow of $-156.82M over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of -3.6 on a per share basis this quarter. Perhaps, that suggests something about why 75.40% of the outstanding share supply is held by institutional investors.
It’s important to check the technicals to get a sense of how has been acting. Looking at the stock’s movement on the chart, Intercept Pharmaceuticals, Inc. recorded a 52-week high of 177.93. It is now trading 72.27 off that level. The stock is trading 106.30 its 50-day moving average by 0.64. The stock carved out a 52-week low down at 89.76.
In recent action, Intercept Pharmaceuticals, Inc. (ICPT) has made a move of -1.51% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 33.42, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 17.63M with 46.83% sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of ICPT.